Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Blood
|
December 9, 2008
Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression
Stephen M Jackson, Natessa Harp, Darshna Patel, et al.
Journal of the American Chemical Society
|
October 28, 2010
Linear 6,6'-biazulenyl framework featuring isocyanide termini: synthesis, structure, redox behavior, complexation, and self-assembly on Au(111)
Tiffany R Maher, Andrew D Spaeth, Brad M Neal, et al.
Inorganic Chemistry
|
October 29, 2015
Probing Electronic Communications in Heterotrinuclear Fe-Ru-Fe Molecular Wires Formed by Ruthenium(II) Tetraphenylporphyrin and Isocyanoferrocene or 1,1'-Diisocyanoferrocene Ligands
Victor N Nemykin, Semyon V Dudkin, Mahtab Fathi-Rasekh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1997
A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis
E Bardet, A Rivière, A Charloux, et al.
Bone Marrow Transplantation
|
November 27, 2007
Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer
P Biron, M Durand, H Roché, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2004
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group
G Giaccone, E F Smit, M de Jonge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2004
Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study
J-Y Douillard, R Gervais, G Dabouis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer
I Treilleux, M Arnedos, C Cropet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study
J L Pujol, J Y Douillard, A Rivière, et al.
BMC Cancer
|
September 25, 2016
Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy
N Houédé, G Locker, C Lucas, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Blood
|
December 9, 2008
Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression
Stephen M Jackson, Natessa Harp, Darshna Patel, et al.
Journal of the American Chemical Society
|
October 28, 2010
Linear 6,6'-biazulenyl framework featuring isocyanide termini: synthesis, structure, redox behavior, complexation, and self-assembly on Au(111)
Tiffany R Maher, Andrew D Spaeth, Brad M Neal, et al.
Inorganic Chemistry
|
October 29, 2015
Probing Electronic Communications in Heterotrinuclear Fe-Ru-Fe Molecular Wires Formed by Ruthenium(II) Tetraphenylporphyrin and Isocyanoferrocene or 1,1'-Diisocyanoferrocene Ligands
Victor N Nemykin, Semyon V Dudkin, Mahtab Fathi-Rasekh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1997
A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis
E Bardet, A Rivière, A Charloux, et al.
Bone Marrow Transplantation
|
November 27, 2007
Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer
P Biron, M Durand, H Roché, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2004
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group
G Giaccone, E F Smit, M de Jonge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2004
Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study
J-Y Douillard, R Gervais, G Dabouis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer
I Treilleux, M Arnedos, C Cropet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study
J L Pujol, J Y Douillard, A Rivière, et al.
BMC Cancer
|
September 25, 2016
Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy
N Houédé, G Locker, C Lucas, et al.
Page
of 5